Cost-effectiveness of a new ACI technique for the treatment of articular cartilage defects of the knee compared to regularly used ACI technique and microfracture

References

• Niemeyer P, Feucht MJ, Fritz J, et al. Cartilage repair surgery for full-thickness defects of the knee in Germany: indications and epidemiological data from the german cartilage registry (KnorpelRegister DGOU). Arch Orthop Trauma Surg. 2016;136:891–897.
   PubMed Web of Science ®Google Scholar
• Arøen A, Løken S, Heir S, et al. Articular cartilage lesions in 993 consecutive knee arthroscopies. Am J Sports Med. 2004;32(1):211–215.
   PubMed Web of Science ®Google Scholar
• Clavé A, Potel J-F, Servien E, et al. Third-generation autologous chondrocyte implantation versus mosaicplasty for knee cartilage injury: 2-year randomized trial. J Orthop Res. 2016;34:658–665.
   PubMed Web of Science ®Google Scholar
• Vanlauwe J, Saris DBF, Victor J, et al. Five-year outcome of characterized chondrocyte implantation versus microfracture for symptomatic cartilage defects of the knee: early treatment matters. Am J Sports Med. 2011;39:2566–2574.
   PubMed Web of Science ®Google Scholar
• Jackson DW, Simon TM, Aberman HM. Symptomatic articular cartilage degeneration. Clin Orthop Relat Res. 2001;391:S14–S25.
   Google Scholar
• Johnson-Nurse C, Dandy DJ. Fracture-separation of articular cartilage in the adult knee. J Bone Joint Surg Br. 1985;67-B:42–43.
   Google Scholar
• Fossum V, Hansen A, Wilsgaard T, et al. Collagen-covered autologous chondrocyte implantation versus autologous matrix-induced chondrogenesis: a randomized trial comparing 2 methods for repair of cartilage defects of the knee. Orthop J Sports Med. 2019;7:2325967119868212.
   Web of Science ®Google Scholar
• Hoburg A, Niemeyer P, Laute V, et al. Matrix-Associated autologous chondrocyte implantation with spheroid technology Is superior to arthroscopic microfracture at 36 months Regarding activities of daily living and sporting activities after treatment. Cartilage. 2021;13:437S–448.
   PubMed Web of Science ®Google Scholar
• Niemeyer P, Albrecht D, Andereya S, et al. Autologous chondrocyte implantation (ACI) for cartilage defects of the knee: a guideline by the working group ‘clinical tissue regeneration’ of the german society of orthopaedics and trauma (DGOU). Knee. 2016;23:426–35.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the knee: technology appraisal guidance [TA477]; 2017. Available from: https://www.nice.org.uk/guidance/TA477/chapter/1-Recommendations.
   Google Scholar
• European Medicines Agency. Spherox – spheroids of human autologous matrix-associated chondrocytes: product information – Annex I – Summary of product characteristics; 2021. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/spherox#product-information-section.
   Google Scholar
• Niemeyer P, Hanus M, Belickas J, et al. Treatment of large cartilage defects in the knee by hydrogel-based autologous chondrocyte implantation: two-year results of a prospective, multicenter, single-arm phase III trial. Cartilage. 2022;13:19476035221085144.
   Web of Science ®Google Scholar
• Vogelmann T, Roessler PP, Buhs M, et al. Long-term cost-effectiveness of matrix-associated chondrocyte implantation in the german health care system: a discrete event simulation. Arch Orthop Trauma Surg. 2023;143(3):1417–1427.
   PubMedGoogle Scholar
• National Institute for Health and Care Excellence (NICE). Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the knee: technology appraisal guidance [TA508]; 2018. Available from: https://www.nice.org.uk/guidance/ta508/documents/html-content-2.
   Google Scholar
• Mistry H, Connock M, Pink J, et al. Autologous chondrocyte implantation in the knee: systematic review and economic evaluation. Health Technol Assess. 2017;21:1–294.
   Web of Science ®Google Scholar
• Saris D, Price A, Drogset JO, et al. SUMMIT prospective, randomized, controlled trial: response rates to matrix-induced autologous chondrocyte implant (MACI) versus microfracture (MFX) by lesion characteristics. Orthop J Sports Med. 2013;1(4 Suppl):2325967113S00029.
   Google Scholar
• Saris DBF, Vanlauwe J, Victor J, et al. Treatment of symptomatic cartilage defects of the knee. Am J Sports Med. 2009;37:10–9.
   PubMed Web of Science ®Google Scholar
• Niemeyer P, Laute V, Zinser W, et al. A prospective, randomized, Open-Label, multicenter, phase III noninferiority trial to compare the clinical efficacy of Matrix-Associated autologous chondrocyte implantation With spheroid technology Versus arthroscopic microfracture for cartilage defects of the knee. Orthop J Sports Med. 2019;7:232596711985444.
   Web of Science ®Google Scholar
• Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. N19-02 – ACI am Kniegelenk – Abschlussbericht – Version 1.1. Published Online First; 2020. Available from: www.iqwig.de.
   Google Scholar
• Annemans L, Genesté B, Jolain B. Early modelling for assessing health and economic outcomes of drug therapy. Value in Health. 2000;3:427–34.
   PubMedGoogle Scholar
• IJzerman MJ, Koffijberg H, Fenwick E, et al. Emerging use of early health technology assessment in medical product development: a scoping review of the literature. Pharmacoeconomics. 2017;35:727–40.
   PubMed Web of Science ®Google Scholar
• Armoiry X, Cummins E, Connock M, et al. Autologous chondrocyte implantation with chondrosphere for treating articular cartilage defects in the knee: an evidence review group perspective of a NICE single technology appraisal. Pharmacoeconomics. 2019;37:879–86.
   PubMed Web of Science ®Google Scholar
• Svendsen VG, Lokkerbol J, Danner UN, et al. Design and testing of a health economic markov model for treatment of anorexia nervosa. Expert Rev Pharmacoecon Outcomes Res. 2022;22:1243–51.
   PubMed Web of Science ®Google Scholar
• Sonnenberg FA, Beck JR. Markov models in medical decision making. Med Dec Mak. 1993;13:322–38.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence, editor. NICE health technology evaluations: the manual. Process and methods; 2022. Available from: www.nice.org.uk/process/pmg36.
   Google Scholar
• Niemeyer P, Angele P, Juras V, et al. Minimally invasive matrix-coupled autologous chondrocyte transplantation (MACT) with a regeneration-promoting hydrogel –0. 40 AGA Congress Abstract Book | 14–16 September 2023 | Berlin; 2022. p. 48. Available from: https://kongressarchiv.aga-kongress.info/wp-content/uploads/2022/10/AGA22_Abstractband.pdf., Abstract AGA22-202
   Google Scholar
• TETEC AG. Data on file: treatment of large cartilage defects in the knee by hydrogel-based autologous chondrocyte implantation: two-year results of a prospective, multicenter, single-arm phase III trial: number of reoperations after one year; 2022.
   Google Scholar
• National Institute for Health and Care Excellence (NICE). Single technology appraisal: autologous chondrocyte implantation with chondrosphere for treating articular cartilage defects [ID851]: committee Papers; 2018. Available from: https://www.nice.org.uk/guidance/ta508/documents/committee-papers.
   Google Scholar
• Office for National Statistics. Death registered in England and Wales: 2020; 2021. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregistrationsummarytables/2020.
   Google Scholar
• Gerlier L, Lamotte M, Wille M, et al. The cost utility of autologous chondrocytes implantation using ChondroCelect in symptomatic knee cartilage lesions in Belgium. Pharmacoeconomics. 2010;28:1129–46.
   PubMed Web of Science ®Google Scholar
• Dong H, Buxton M. Early assessment of the likely cost-effectiveness of a new technology: a markov model with probabilistic sensitivity analysis of computer-assisted total knee replacement. Int J Technol Assess Health Care. 2006;22:191–202.
   PubMed Web of Science ®Google Scholar
• Jansson K-Å, Granath F. Health-related quality of life (EQ-5D) before and after orthopedic surgery. Acta Orthop. 2011;82:82–89.
   PubMed Web of Science ®Google Scholar
• PSSRU. Unit costs of health & social care 2016; 2016. Available from: https://www.pssru.ac.uk/pub/uc/uc2016/full.pdf?uc=2016-full.
   Google Scholar
• National Health Service. National reference costs 2015–16; 2015. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/577083/Reference_Costs_2015-16.pdf.
   Google Scholar
• Gray AM, Clarke PM, Wolstenholme JL, et al. Applied methods of cost-effectiveness analysis in health care. New York: Oxford University Press; 2011.
   Google Scholar
• Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ. 2001;10:779–787.
   PubMed Web of Science ®Google Scholar
• Chilcott J, Brennan A, Booth A, et al. The role of modelling in prioritising and planning clinical trials. Health Technol Assess. 2003;7(23):iii, 1–125.
   PubMedGoogle Scholar
• Briggs AH, Karl C, Sculpher MJ. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006;237.
   Google Scholar
• Wilson ECF. A practical guide to value of information analysis. Pharmacoeconomics. 2015;33(2):105–121.
   PubMed Web of Science ®Google Scholar
• Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998;18(2 Suppl):S68–S80.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). Final appraisal determination: autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the knee; 2017. Available from: https://www.nice.org.uk/guidance/ta508/documents/final-appraisal-determination-document.
   Google Scholar
• Pinho-Gomes A-C, Cairns J. Evaluation of advanced therapy medicinal products by the national institute for health and care excellence (NICE): an updated review. Pharmacoecon Open. 2022;6(2):147–167.
   PubMed Web of Science ®Google Scholar
• Saris D, Price A, Widuchowski W, SUMMIT Study Group, et al. Matrix-applied characterized autologous cultured chondrocytes versus microfracture. Am J Sports Med. 2014;42(6):1384–1394.
   PubMed Web of Science ®Google Scholar
• Knutsen G, Drogset J, Engebretsen L, et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. J Bone Joint Surg Am. 2007;89:2105–2112.
   PubMed Web of Science ®Google Scholar